Consistently, the number of Vimentin+p-SMAD3+ cells was significantly increased in BLM-treated mice, and EchA treatment completely normalized the number of Vimentin+pSMAD3+ cells in BLM-treated mice skin (Figure 2B,E). This evidence concerns the gene SMAD3 and Bloom syndrome.